<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: 14-3-3ε regulates diverse biological processes and plays a significant role in the formation of <z:mp ids='MP_0002018'>malignant tumors</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the localization and clinical significance of 14-3-3ε in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) have not been elucidated </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We investigated 14-3-3ε expression and its prognostic significance in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> surgical samples were taken from 137 clinicopathologically characterized <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cases </plain></SENT>
<SENT sid="4" pm="."><plain>14-3-3ε expression was tested by immunohistochemical assay </plain></SENT>
<SENT sid="5" pm="."><plain>Separate Western blot of nuclear and cytosol preparations confirmed nuclear localization of 14-3-3ε protein </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Nuclear expression of 14-3-3ε was observed in 76.9% of <z:mpath ids='MPATH_458'>normal</z:mpath> colorectal tissue and 78.8% of <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> samples </plain></SENT>
<SENT sid="7" pm="."><plain>Statistical analysis showed that there was significant difference of nuclear 14-3-3ε expression in patients categorized according to lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>A trend was identified between decreasing nuclear 14-3-3ε expression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and worsening clinical prognosis </plain></SENT>
<SENT sid="9" pm="."><plain>Multivariate analysis showed that loss of nuclear 14-3-3ε expression was an independent prognostic indicator for patient's survival </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: The current data provide evidence that 14-3-3ε is not exclusively a cytosolic protein, but is also detectable within the nucleus </plain></SENT>
<SENT sid="11" pm="."><plain>Our results suggest that nuclear 14-3-3ε as a suppressor may serve as important biomarker of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">tumor metastasis</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Loss of nuclear 14-3-3ε is closely associated with poor overall survival in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
</text></document>